Table 4.
Influence of H. pylori eradication therapy on the symptoms of DGP, n (%)
| Symptoms | Before H. pylori eradication | After H. pylori eradication | ||
|---|---|---|---|---|
| DGP patients (n = 53) | NDG patients (n = 29) | DGP patients (n = 53) | NDG patients (n = 29) | |
| Upper abdominal pain | 40 (75.5) | 22 (73.3) | 23 (43.4)* | 20 (66.7) |
| Early satiety | 35 (66.0) | 18 (60.0) | 19 (35.8)† | 16 (53.3) |
| Nausea | 34 (64.2) | 19 (63.3) | 28 (52.8) | 17 (56.7) |
| Vomiting | 19 (35.8) | 9 (30.0) | 12 (22.6) | 8 (23.3) |
| Anorexia | 36 (67.9) | 20 (60.0) | 21 (39.6)‡ | 15 (50.0) |
*χ2 = 11.308, P<0.01, †χ2 = 9.664, P<0.01, ‡χ2 = 8.539, P<0.01, compared with the incidences before H. pylori eradication therapy. DGP: Diabetic gastroparesis; NDG: Nondiabetic gastroparesis; H. pylori: Helicobacter pylori.